Skip to main content
Atrás
ARRJF logo

Arjo AB (publ)

Calidad de datos: 100%
Sobreventa
ARRJF
OTC Healthcare Medical - Distribution
$2.97
$0.00 (0.00%)
Cap. Mercado: 807.58M
Rango del Día
$2.97 $3.51
Rango de 52 Semanas
$2.97 $3.51
Volumen
325
Promedio 50D / 200D
$3.17 / $3.19
Cierre Anterior
$2.97

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (627 pares)

Métrica Acción Mediana del Sector
P/E 2.4 0.3
P/B 0.1 2.9
ROE % 4.2 3.7
Net Margin % 3.0 3.8
Rev Growth 5Y % 4.9 10.0
D/E 0.2 0.2

Precio Objetivo de Analistas

No hay cobertura de analistas disponible

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2028 $2.64
$2.59 – $2.68
 12 B 1
FY2027 $2.28
$2.24 – $2.31
 11 B 1
FY2026 $1.97
$1.94 – $2.00
 11 B 1

Puntos Clave

Revenue grew 4.94% annually over 5 years — modest growth
Earnings declined -32.93% over the past year
ROE of 4.23% is below average
Debt/Equity of 0.17 — conservative balance sheet
Generating 755.10M in free cash flow
P/E of 2.42 — trading at a low valuation

Crecimiento

Revenue Growth (5Y)
4.94%
Revenue (1Y)-2.59%
Earnings (1Y)-32.93%
FCF Growth (3Y)-28.01%

Calidad

Return on Equity
4.23%
ROIC7.14%
Net Margin3.04%
Op. Margin7.55%

Seguridad

Debt / Equity
0.17
Current Ratio1.83
Interest Coverage3.99

Valoración

P/E Ratio
2.42
P/B Ratio0.11
EV/EBITDA1.49
Dividend Yield0.03%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -2.59% Revenue Growth (3Y) 0.09%
Earnings Growth (1Y) -32.93% Earnings Growth (3Y) -16.58%
Revenue Growth (5Y) 4.94% Earnings Growth (5Y) -18.09%
Profitability
Revenue (TTM) 11.00B Net Income (TTM) 334.00M
ROE 4.23% ROA 2.23%
Gross Margin 39.13% Operating Margin 7.55%
Net Margin 3.04% Free Cash Flow (TTM) 755.10M
ROIC 7.14% FCF Growth (3Y) -28.01%
Safety
Debt / Equity 0.17 Current Ratio 1.83
Interest Coverage 3.99 Dividend Yield 0.03%
Valuation
P/E Ratio 2.42 P/B Ratio 0.11
P/S Ratio 0.07 PEG Ratio -0.76
EV/EBITDA 1.49 Dividend Yield 0.03%
Market Cap 807.58M Enterprise Value 1.24B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 11.00B 11.29B 10.98B 9.98B 9.07B
Net Income 334.00M 498.00M 480.00M 449.00M 742.00M
EPS (Diluted) 1.23 1.83 1.76 1.65 2.72
Gross Profit 4.30B 4.91B 4.74B 4.21B 4.21B
Operating Income 831.00M 893.00M 884.00M 691.00M 1.08B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 14.98B 16.28B 15.44B 16.17B 14.61B
Total Liabilities 7.52B 7.94B 7.86B 8.54B 7.73B
Shareholders' Equity 7.46B 8.34B 7.58B 7.62B 6.89B
Total Debt 1.27B 5.42B 5.49B 6.31B 5.45B
Cash & Equivalents 836.00M 892.00M 923.00M 949.00M 757.00M
Current Assets 4.32B 4.85B 4.42B 5.03B 4.17B
Current Liabilities 2.37B 4.60B 4.40B 4.62B 6.49B

Puntuaciones de Estrategias

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Deep Value Investing (Seth Klarman)
#551 of 827
35
Value Defensive Investing (Benjamin Graham)
#161 of 709
46

Actividad Reciente

Entró Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entró Defensive Investing (Benjamin Graham)
Mar 24, 2026